Sexually transmitted infections (STIs) are on the rise in the UK, with chlamydia standing out as the most reported. Despite its ease of treatment, many cases remain undetected due to a lack of symptoms, leading to long-term health risks such as pelvic inflammatory disease and infertility. Recent research highlights significant barriers to testing, which contribute to the underutilisation of available services and the ongoing spread of the infection. The findings were published in Psychreg Journal of Psychology.
In 2012, over 206,000 individuals in England tested positive for chlamydia, with nearly two-thirds of cases involving those under the age of 25. While the National Chlamydia Screening Programme (NCSP) offers confidential testing, various obstacles deter individuals from accessing these services. Key among these is stigma. Social perceptions often associate STI testing with promiscuity, creating feelings of embarrassment and judgement. This stigma can be particularly acute in clinic environments, where attendees may fear being identified or labelled by others.
Natalie Quinn-Walker, a lecturer at Birmingham City South Campus – Seacole and a former sexual health specialist, said: “A key issue that I want to address is the lack of awareness and stigma associated with STIs. I noted, when working in the sector, that there was still an association of STIs with promiscuous behaviour and that it ‘wouldn’t happen to me’ attitude.”
Education gaps compound the problem. Many individuals, especially younger people, lack an understanding of chlamydia’s risks and symptoms. Research has shown that misconceptions about the infection are widespread, with some perceiving it as a minor issue due to its curable nature. However, untreated chlamydia can result in severe complications, including infertility, which underscores the importance of timely diagnosis and treatment.
Testing methods also play a role in discouraging participation. While home testing kits and general practice (GP) settings are available, some individuals find these options inconvenient or uncomfortable. Invasive testing techniques, though largely discontinued, have left lingering fears that persist even with modern, less intrusive methods. Addressing these concerns may require targeted efforts to normalise testing and reassure individuals about the simplicity of current procedures.
Quinn-Walker also highlighted how reduced availability of sexual health services impacts access: “The study’s motivation was to explore the obstacles further, considering social and cultural factors that may prevent individuals from seeking testing services. Emphasises more needs to be done to address the issue, especially as the number of sexual health services that offer testing within communities has reduced in number due to funding cuts.”
The NCSP, established in 2003, aims to reduce chlamydia prevalence by increasing awareness and access to testing. While the programme has made significant strides, challenges remain. Experts suggest that routine STI testing during GP consultations could help normalise the practice and alleviate stigma. GPs are often viewed as trusted sources of care, making them well-positioned to encourage testing in a non-judgemental environment. However, financial incentives may be necessary to enhance GP participation in these efforts.
Community engagement and educational campaigns are also critical. Informing the public about chlamydia’s risks and encouraging preventive behaviours could shift attitudes and reduce stigma. Schools, youth centres, and social media platforms may serve as effective channels for disseminating this information, particularly to high-risk groups.
Quinn-Walker emphasised the importance of these approaches: “We must normalise STI testing and awareness, building it into people’s health MOT checks. Testing services need to be more available, with home kits being offered alongside supportive agencies to assist in diagnosis.”
The rise in chlamydia cases among young people underscores an urgent need for a multi-faceted approach. Addressing barriers to testing, improving education, and integrating STI screening into routine healthcare could significantly reduce infection rates and improve public health outcomes. Quinn-Walker concluded by noting the potential of innovative solutions: “For future plans, I intend to focus on conducting further research exploring the barriers and sourcing initiatives to assist in overcoming these barriers. Furthermore, I intend to investigate how digital technologies and social media can combat stigma, prompt discussions around STIs, and encourage more people to regularly access STI testing services. The key aim is to normalise STI testing.”
